Vitalpoint Technologies Appoints Dr. Joseph Rosado, MD, MBA to the role of Chief Medical Officer with a Focus on Ketamine Research and Accessibility

Dr. Joseph Rosado has been named Chief Medical Officer at VitalPoint Technologies Inc., where he will oversee increasing access to new ketamine therapies. Dr. Rosado brings a wealth of experience from his extensive career in healthcare, including expertise in clinical nutrition and healthcare management. He has held significant leadership roles and is currently the medical […]

Vitalpoint Technologies Appoints Dr. Joseph Rosado, MD, MBA to the role of Chief Medical Officer with a Focus on Ketamine Research and Accessibility Read More »